["[Tab] Consolidated Balance Sheets from Baxter International\n\n[Time]: December 31, 2023 [SEP]\n[row 0]: Current assets [SEP]\n[row 1]: Cash and cash equivalents | $3,194 [SEP]\n[row 2]: Accounts receivable, net of allowance of $129 | $2,690 [SEP]\n[row 3]: Inventories | $2,824 [SEP]\n[row 4]: Prepaid expenses and other current assets | $892 [SEP]\n[row 5]: Current assets of discontinued operations | \u2014 [SEP]\n[row 6]: Total current assets | $9,600 [SEP]\n[row 7]: Property, plant and equipment, net | $4,433 [SEP]\n[row 8]: Goodwill | $6,514 [SEP]\n[row 9]: Other intangible assets, net | $6,079 [SEP]\n[row 10]: Operating lease right-of-use assets | $524 [SEP]\n[row 11]: Other non-current assets | $1,126 [SEP]\n[row 12]: Non-current assets of discontinued operations | - [SEP]\n[row 13]: Total assets | $28,276 [SEP]\n[row 14]: Current liabilities [SEP]\n[row 15]: Short-term debt | $\u2014 [SEP]\n[row 16]: Current maturities of long-term debt and finance lease obligations | $2,668 [SEP]\n[row 17]: Accounts payable | $1,241 [SEP]\n[row 18]: Accrued expenses and other current liabilities | $2,594 [SEP]\n[row 19]: Current liabilities of discontinued operations | \u2014 [SEP]\n[row 20]: Total current liabilities | $6,503 [SEP]\n[row 21]: Long-term debt and finance lease obligations, less current portion | $11,130 [SEP]\n[row 22]: Operating lease liabilities | $438 [SEP]\n[row 23]: Other non-current liabilities | $1,737 [SEP]\n[row 24]: Non-current liabilities of discontinued operations | - [SEP]\n[row 25]: Total liabilities | $19,808 [SEP]\n[row 26]: Commitments and contingencies | [SEP]\n[row 27]: Equity | [SEP]\n[row 28]: Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2023 and 2022 | $683 [SEP]\n[row 29]: Common stock in treasury, at cost, 175,861,893 shares in 2023 and 179,062,594 shares in 2022 | ($11,230) [SEP]\n[row 30]: Additional contributed capital | $6,389 [SEP]\n[row 31]: Retained earnings | $16,114 [SEP]\n[row 32]: Accumulated other comprehensive income (loss) | ($3,554) [SEP]\n[row 33]: Total Baxter stockholders\u2019 equity | $8,402 [SEP]\n[row 34]: Noncontrolling interests | $66 [SEP]\n[row 35]: Total equity | $8,468 [SEP]\n[row 36]: Total liabilities and equity | $28,276 [SEP]\n\n[Time]: December 31, 2022 [SEP]\n[row 0]: Current assets [SEP]\n[row 1]: Cash and cash equivalents | $1,718 [SEP]\n[row 2]: Accounts receivable, net of allowance of $114 | $2,571 [SEP]\n[row 3]: Inventories | $2,679 [SEP]\n[row 4]: Prepaid expenses and other current assets | $857 [SEP]\n[row 5]: Current assets of discontinued operations | $186 [SEP]\n[row 6]: Total current assets | $8,011 [SEP]\n[row 7]: Property, plant and equipment, net | $4,695 [SEP]\n[row 8]: Goodwill | $6,452 [SEP]\n[row 9]: Other intangible assets, net | $6,793 [SEP]\n[row 10]: Operating lease right-of-use assets | $541 [SEP]\n[row 11]: Other non-current assets | $1,109 [SEP]\n[row 12]: Non-current assets of discontinued operations | $686 [SEP]\n[row 13]: Total assets | $28,287 [SEP]\n[row 14]: Current liabilities [SEP]\n[row 15]: Short-term debt | $299 [SEP]\n[row 16]: Current maturities of long-term debt and finance lease obligations | $1,105 [SEP]\n[row 17]: Accounts payable | $1,110 [SEP]\n[row 18]: Accrued expenses and other current liabilities | $2,170 [SEP]\n[row 19]: Current liabilities of discontinued operations | $61 [SEP]\n[row 20]: Total current liabilities | $4,745 [SEP]\n[row 21]: Long-term debt and finance lease obligations, less current portion | $15,232 [SEP]\n[row 22]: Operating lease liabilities | $447 [SEP]\n[row 23]: Other non-current liabilities | $1,848 [SEP]\n[row 24]: Non-current liabilities of discontinued operations | $120 [SEP]\n[row 25]: Total liabilities | $22,392 [SEP]\n[row 26]: Commitments and contingencies | [SEP]\n[row 27]: Equity | [SEP]\n[row 28]: Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2023 and 2022 | $683 [SEP]\n[row 29]: Common stock in treasury, at cost, 175,861,893 shares in 2023 and 179,062,594 shares in 2022 | ($11,389) [SEP]\n[row 30]: Additional contributed capital | $6,322 [SEP]\n[row 31]: Retained earnings | $14,050 [SEP]\n[row 32]: Accumulated other comprehensive income (loss) | ($3,833) [SEP]\n[row 33]: Total Baxter stockholders\u2019 equity | $5,833 [SEP]\n[row 34]: Noncontrolling interests | $62 [SEP]\n[row 35]: Total equity | $5,895 [SEP]\n[row 36]: Total liabilities and equity | $28,287 [SEP]"]